In general, the following genes distinguished GD from both NPC patients and controls: PLAU, IFIT1, TMEM158 (up-regulated in GD), ATOH8 and ISLR (down-regulated in GD). This evidence concerns the gene PLAU and nasopharyngeal carcinoma.